Arrowhead Research Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 22 Posts
1 2
Stock Charts To Watch - August 19, 2019
Video By: Harry Boxer Monday, August 19, 2019 5:14 PM EDT
Amyris, Inc. had a really good session on Monday, jumping 74 cents, or 20%, to 4.41, on 1.5 million shares. Arrowhead Pharmaceuticals, Neogen Corp., Perion Network, SunPower Corp., and XPO Logistics look good as well. Let's take a closer look
In this video: XPO, PERI, AMRS, NEOG, SPWR, ARWR
Watch
Healthcare And Biotechs Feel The Heat As The Market At New Highs
Article By: Tarun Chandra, CFA Wednesday, May 1, 2019 12:14 PM EDT
The stock market has continued to edge higher and the two major indexes, the Nasdaq (QQQ) and S&P 500 (SPY​), touched the all-time high milestone last week.
In this article: ACAD, ALXN, ARRY, AMRN, ARWR, AXSM, ASND
Read
Looking Ahead Of Wall Street: Arrowhead Research Corp, Oracle Corporation, And BlackBerry Ltd.
Article By: TipRanks Monday, December 14, 2015 2:43 AM EDT
Holiday shopping and festivities are in full swing, but several companies are slated to report earnings this week ahead of the holidays.
In this article: ORCL, ARWR, BBRY (NOW BB)
Read
E Arrowhead Reports Positive Phase 2a Trial Results For Patients With Hepatitis B
Article By: Terry Chrisomalis Thursday, September 24, 2015 6:37 PM EDT
Shares of Arrowhead surged 21% after announcing positive phase 2a trial results for its Hepatitis B drug ARC-520.
In this article: ARWR
Read
E Arrowhead Cleared By FDA For Phase 2b Hepatitis B Study
Article By: Terry Chrisomalis Monday, April 13, 2015 10:30 PM EDT
The drug known as ARC-520 has been cleared by the FDA to proceed with multi-dose trial in hepatitis B patients but shares only briefly rallied before returning flat.
In this article: ARWR
Read
Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B
Article By: Terry Chrisomalis Tuesday, December 16, 2014 2:48 PM EDT
(ARWR) jumped 10% today, after the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.
In this article: GILD, ARWR
Read
E Small Cap Best & Worst Report - November 20, 2014
Article By: E.B. Capital Markets Thursday, November 20, 2014 9:16 AM EDT
The average small cap score is 53.77, below the four week moving average score of 53.89.
In this article: AIQ, CDE, EBS, ANAC, BELFB, CENT, DRYS, NTRI, PENN, RSTI, ARWR, CYTR
Read
ARWR Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi; TPIV Announces Phase II Clinical Trials With VGTI Florida
Article By: BioMedReports Wednesday, November 19, 2014 3:29 AM EDT
ARWR today announced that it recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate.TPIV. is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida.
In this article: TPIV, ARWR
Read
E Small Cap Best And Worst Report - November 13, 2014
Article By: E.B. Capital Markets Thursday, November 13, 2014 9:05 AM EDT
The average small cap score is 54.59, above the four week moving average score of 53.22. The average small cap is trading -27.26% below its 52 week high, 0.86% above its 200 dma, and has 9.05 days to cover held short.
In this article: AIQ, CDE, MEI, XOXO, ANAC, BELFB, DRYS, NTRI, ARWR, CYTR
Read
E Small Cap Best & Worst Report - November 6, 2014
Article By: E.B. Capital Markets Thursday, November 6, 2014 8:49 AM EDT
The average small cap score is 56.11, above the four week moving average score of 51.12.
In this article: CMN, GSS, ANAC, SIGA, BELFB, CFNL, CMTL, DRYS, ARWR, ESMC
Read
Consider The 2-3x Upside In This Most Overlooked Hepatitis B Stock
Article By: Jake King Tuesday, November 4, 2014 1:32 PM EDT
GlobeImmune IPO’d in June to little fanfare and has underperformed the biotech sector considerably since then. A key driving event in the next six months should put it back on the radar.
In this article: ALNY, CELG, GILD, ARWR, GBIM
Read
E Small Cap Best And Worst Report - October 16, 2014
Article By: E.B. Capital Markets Thursday, October 16, 2014 8:48 AM EDT
The average small cap score is 46.22 this week, below the four week moving average score of 48.59. The average small cap is trading -32.93% below its 52 week high, -10.40% below its 200 dma, and has 10.50 days to cover held short. Short interest is near historically actionable levels.
In this article: AIQ, CMN, AFAM, ANAC, RGEN, SIGA, CENT, XRTX, ARWR, ESMC
Read
E Arrowhead Drops On Phase 2 Hepatitis B Results, Opportunity To Buy Shares
Article By: Terry Chrisomalis Friday, October 10, 2014 10:04 AM EDT
Arrowhead Research Corp tumbles on Hepatitis B data
In this article: ARWR
Read
Healthcare Review: OBCI, RGBP, ARWR, UNIS, SLXP
Article By: BioMedReports Wednesday, October 8, 2014 4:14 PM EDT
U.S. stocks extended gains as investors speculated the Federal Reserve would keep interest rates lower for longer on concern that a global slowdown will hurt the American economy.
In this article: SLXP, UNIS, ARWR, OBCI, RGBP
Read
RXi Pharmaceuticals Posts Positive Phase 2a 3-Month Results In Hypertrophic Scars
Article By: Terry Chrisomalis Tuesday, October 7, 2014 3:13 PM EDT
This validation is important because now the company is at a reduced risk investment level.
In this article: TKMR, ARWR, RXII
Read
Rxi Pharmaceuticals Is Ready To Show The True Power Of Its Technology Platform
Article By: Terry Chrisomalis Wednesday, September 3, 2014 9:15 PM EDT
Rxi Pharmaceuticals to Showcase phase 2a hypertrophic scar Results and other data
In this article: AGN, TKMR, ARWR, RXII
Read
1 to 16 of 22 Posts
1 2